Merestinib Recruiting Phase 1 Trials for Cancer, Breast / Bone Metastases Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03292536Merestinib on Bone Metastases in Subjects With Breast Cancer